Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Docru P 60mg/325mg Tablet

Prescription Icon
Prescription Required

Marketer

Arlak Biotech Pvt Ltd

Salt Composition

Etoricoxib (60mg) + Paracetamol (325mg)

Overview Docru P 60mg/325mg Tablet

RheumaSolve 60mg/325mg tablets offer pain relief and inflammation reduction. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It can also alleviate muscle, back, tooth, ear, and throat pain. RheumaSolve can be administered with or without food, always following your physician's prescribed regimen. Dosage and frequency may be adjusted based on individual pain levels and response. Never exceed the recommended dosage or duration. Common side effects include diarrhea, dyspepsia, abdominal pain, flatulence, edema (hands and feet), and influenza-like symptoms. Persistent or bothersome side effects warrant immediate medical attention; your doctor can explore alternative medications or dosage modifications. This medication isn't universally suitable. Individuals with cardiac, renal, hepatic issues, or stomach ulcers should consult their physician before use. Comprehensive disclosure of all current medications is essential for safe administration. Pregnant and lactating individuals must seek medical advice prior to use.

Uses of Docru P 60mg/325mg Tablet

Analgesia

Major Benefits of Docru P 60mg/325mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Docru P 60mg/325mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.

Common Side effects of Docru P 60mg/325mg Tablet:

  • Diarrhea
  • Indigestion
  • Stomach pain
  • Flatulence
  • Swelling of hands
  • Feet swelling
  • Flu-like symptoms

How to use Docru P 60mg/325mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 60mg/325mg Docru P tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistent timing is recommended for optimal results.

How Docru P 60mg/325mg Tablet works:

Each Docru P 60mg/325mg tablet unites Etoricoxib, a non-steroidal anti-inflammatory drug (NSAID), with Paracetamol, an antipyretic. This dual action targets pain and fever by inhibiting the production of specific inflammatory mediators within the central nervous system.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Docru P 60mg/325mg Tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Docru P 60mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Docru P 60mg/325mg tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a Docru P 60mg/325mg Tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Individuals with impaired kidney function should exercise caution when taking Docru P 60mg/325mg tablets, as dosage modification may be necessary. Patients with severe kidney disease should avoid this medication; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use 60mg/325mg Docru P tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Docru P 60mg/325mg tablets are contraindicated for individuals with severe or active liver disease.

What if you forget to take Docru P 60mg/325mg Tablet :

Should you forget a Docru P 60mg/325mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Docru P 60mg/325mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medications for Pain Relief

FAQs on Docru P 60mg/325mg Tablet

Dizziness, including faintness, weakness, unsteadiness, or lightheadedness, is a potential side effect of Docru P 60mg/325mg Tablet in some individuals. Should dizziness occur, rest is recommended until symptoms subside.
Patients with documented hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) or any constituent of Docru P 60mg/325mg Tablet should not use this medication. This medicine is contraindicated in individuals with a history of peptic ulcers, active or recurrent gastrointestinal bleeding, or those with pre-existing heart failure, hypertension, hepatic impairment, or renal dysfunction.
Chronic consumption of Docru P 60mg/325mg tablets can indeed impair kidney function. Healthy kidneys naturally produce prostaglandins, chemicals that safeguard against such damage. Analgesic use diminishes prostaglandin levels, increasing the risk of kidney harm with prolonged administration. Individuals with pre-existing kidney conditions should avoid using these painkillers.
Increasing the dosage of this medication won't enhance its efficacy; instead, it may heighten the risk of adverse reactions. If your symptoms worsen, seek a physician's assessment.
Docru P 60mg/325mg tablets include paracetamol, a medication potentially harmful to the liver, particularly when exceeding the recommended dosage. Concurrent alcohol consumption is strongly discouraged due to the increased risk of liver injury. Patients with pre-existing liver conditions should generally abstain from using this medication. Seek immediate medical attention if you experience potential liver damage indicators such as fever, skin rash, anorexia, nausea, emesis, malaise, abdominal pain, dark urine, jaundice, or elevated liver function tests.
Store the medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
For persistent pain, the 60mg/325mg Docru P Tablet regimen should continue as directed by your physician. Its use for temporary pain may be ceased when the need subsides.
Docru P 60mg/325mg Tablet
78
MRP 96
18% off